Zymeworks annual free cash flow
2020
2021
2022
2023
2024
2025
Zymeworks Free Cash Flow (FCF) History (ZYME)
Zymeworks reported −$34.5M in free cash flow for fiscal 2025, an increase of $77.5M from the previous fiscal year, with a free cash flow margin of −32.58%.
View full Zymeworks company overviewZymeworks free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$34.5M | $77.5M | — | −32.58% |
| 2024 | 2024-12-31 | −$112.0M | $8.7M | — | −146.85% |
| 2023 | 2023-12-31 | −$120.8M | −$256.8M | — | −158.92% |
| 2022 | 2022-12-31 | $136.0M | $340.8M | — | +32.96% |
| 2021 | 2021-12-31 | −$204.9M | −$49.1M | — | −767.82% |
| 2020 | 2020-12-31 | −$155.7M | — | — | −399.77% |
Zymeworks quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$31.9M | −$43.5M | — | −696.03% |
| Q1 2026 | 2026-03-31 | −$45.9M | −$42.5M | — | −1907.56% |
| Q4 2025 | 2025-12-31 | −$10.8M | $31.0M | — | −431.01% |
| Q3 2025 | 2025-09-30 | −$31.8M | −$25.0M | — | −115.24% |
| Q2 2025 | 2025-06-30 | $11.6M | $37.1M | — | +23.72% |
| Q1 2025 | 2025-03-31 | −$3.4M | $34.4M | — | −12.63% |
| Q4 2024 | 2024-12-31 | −$41.8M | −$55.4M | — | −134.78% |
| Q3 2024 | 2024-09-30 | −$6.8M | $36.8M | — | −42.37% |
| Q2 2024 | 2024-06-30 | −$25.6M | −$18.4M | — | −132.96% |
| Q1 2024 | 2024-03-31 | −$37.9M | $45.7M | — | −377.47% |
| Q4 2023 | 2023-12-31 | $13.6M | −$313.4M | −95.85% | +80.21% |
| Q3 2023 | 2023-09-30 | −$43.6M | $30.4M | — | −264.13% |
| Q2 2023 | 2023-06-30 | −$7.2M | $50.3M | — | −102.84% |
| Q1 2023 | 2023-03-31 | −$83.6M | −$24.0M | — | −234.91% |
| Q4 2022 | 2022-12-31 | $327.0M | — | — | +81.25% |
| Q3 2022 | 2022-09-30 | −$74.0M | — | — | −2812.47% |
| Q2 2022 | 2022-06-30 | −$57.5M | — | — | −1056.36% |
| Q1 2022 | 2022-03-31 | −$59.6M | — | — | −3109.08% |
Zymeworks free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$155.7M to −$34.5M, a net increase of $121.2M. Zymeworks's latest reported quarter, Q2 2026, generated −$31.9M in free cash flow, a decrease of $43.5M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Zymeworks filings at SEC.gov ↗